⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182296 | 1.00 | — | — | |
| SCHEMBL24483 | 1.00 | — | — | |
| Fluoride SCHEMBL28181807 | 0.97 | — | — | |
| Water SCHEMBL27877032 | 0.97 | — | — | |
| Bromide SCHEMBL5073250 | 0.97 | — | — | |
| Bromide SCHEMBL5073248 | 0.97 | — | — | |
| SCHEMBL29961400 | 0.97 | — | — | |
| Methylamine SCHEMBL11681719 | 0.95 | HCAR2 (0.58) | — | |
| Alcohol SCHEMBL16053498 | 0.95 | HCAR2 (0.58) | — | |
| Methylamine SCHEMBL28259823 | 0.95 | HCAR2 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230182462-A1 | METHOD FOR COMPOSITE DELAMINATION | GRST INTERNATIONAL LIMITED (CN) | 2023-06-15 | — | — | US | claimed |
| US-20230136670-A1 | METHOD FOR COMPOSITE DELAMINATION | GRST SINGAPORE PTE. LTD. (SG) | 2023-05-04 | — | — | US | claimed |
| US-20250380732-A1 | AEROSOLISABLE FORMULATION | NICOVENTURES TRADING LTD (GB) | 2025-12-18 | — | — | US | disclosed |
| US-20250241356-A1 | ORAL COMPOSITION COMPRISING RECEPTOR MODULATOR | DANIEL MICHAEL S (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250205167-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SAIL BIOMEDICINES, INC. | 2025-06-26 | — | — | US | disclosed |
| CN-119955196-A | Food packaging box based on polyethylene plastic and production method thereof | 东莞市瑞翔包装制品有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4543230-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| EP-4543229-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| EP-4499607-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | Sail Biomedicines, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-119072464-A | Novel ionizable lipids and lipid nanoparticles and methods of use thereof | 赛欧生物医药股份有限公司 | 2024-12-03 | — | — | CN | disclosed |
| WO-2023247962-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |
| US-20110269994-A1 | METHOD OF PRODUCING A TRIARYLAMINE COMPOUND | FUJIFILM CORPORATION (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-1954274-B1 | SUBSTITUTED QUINOLONES AND METHODS OF USE | CHEMOCENTRYX INC (US) | 2010-11-03 | — | — | EP | disclosed |
| US-20100248390-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS | DUKE UNIVERSITY (US) | 2010-09-30 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-7393985-B2 | Supported ruthenium nanoparticle catalyst for cis -dihydroxylation and oxidative cleavage of alkenes | THE UNIVERSITY OF HONG KONG (CN) | 2008-07-01 | — | — | US | disclosed |
| US-7354946-B2 | prominent growth inhibitory activity against tumor cells; cyclin dependent kinase inhibitors; colon cancer; N'-(3-t-butylisoindolino[3,2-b]oxazolidin-4-on-8-yl)-N-(4-(N-benzylpyrrolidin-3-yl)pyridin-2-yl)urea | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-08 | — | — | US | disclosed |
| US-7354946-B2 | prominent growth inhibitory activity against tumor cells; cyclin dependent kinase inhibitors; colon cancer; N'-(3-t-butylisoindolino[3,2-b]oxazolidin-4-on-8-yl)-N-(4-(N-benzylpyrrolidin-3-yl)pyridin-2-yl)urea | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-08 | — | — | US | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |